ATE448298T1 - Il-21-produktion in prokaryontischen wirten - Google Patents

Il-21-produktion in prokaryontischen wirten

Info

Publication number
ATE448298T1
ATE448298T1 AT03810068T AT03810068T ATE448298T1 AT E448298 T1 ATE448298 T1 AT E448298T1 AT 03810068 T AT03810068 T AT 03810068T AT 03810068 T AT03810068 T AT 03810068T AT E448298 T1 ATE448298 T1 AT E448298T1
Authority
AT
Austria
Prior art keywords
coli
prokaryontic
hosts
production
expression
Prior art date
Application number
AT03810068T
Other languages
English (en)
Inventor
Chung Chang
Bruce Zamost
Douglas Covert
Hong Liu
Jongh Karen De
Jeffrey Meyer
Susan Holderman
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE448298T1 publication Critical patent/ATE448298T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT03810068T 2002-12-13 2003-12-12 Il-21-produktion in prokaryontischen wirten ATE448298T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43344802P 2002-12-13 2002-12-13
US43345202P 2002-12-13 2002-12-13
PCT/US2003/039764 WO2004055168A2 (en) 2002-12-13 2003-12-12 Il-21 production in prokaryotic hosts

Publications (1)

Publication Number Publication Date
ATE448298T1 true ATE448298T1 (de) 2009-11-15

Family

ID=32600150

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03810068T ATE448298T1 (de) 2002-12-13 2003-12-12 Il-21-produktion in prokaryontischen wirten

Country Status (17)

Country Link
US (4) US7250274B2 (de)
EP (1) EP1573006B1 (de)
JP (1) JP4664684B2 (de)
KR (1) KR101098897B1 (de)
AT (1) ATE448298T1 (de)
AU (1) AU2003302250B2 (de)
BR (1) BR0317243A (de)
CA (1) CA2507817C (de)
DE (1) DE60330044D1 (de)
DK (1) DK1573006T3 (de)
ES (1) ES2334127T3 (de)
IL (2) IL168697A (de)
MX (1) MXPA05006117A (de)
NO (1) NO334561B1 (de)
PL (1) PL209009B1 (de)
RU (1) RU2354703C2 (de)
WO (1) WO2004055168A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307024B1 (en) 1999-03-09 2001-10-23 Zymogenetics, Inc. Cytokine zalpha11 Ligand
WO2004112703A2 (en) * 2003-06-19 2004-12-29 Centocor, Inc. Interleukin-21 analogs
US20060228331A1 (en) * 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
CN1867581B (zh) * 2003-10-10 2012-02-01 诺沃挪第克公司 Il-21衍生物
EP2641611A3 (de) 2003-10-17 2013-12-18 Novo Nordisk A/S Kombinationstherapie
BRPI0511187A (pt) * 2004-05-20 2007-12-04 Zymogenetics Inc método para tratar cáncer em um indivìduo
CA2604222A1 (en) 2005-04-18 2006-10-26 Novo Nordisk A/S Il-21 variants
CA2608579C (en) * 2005-05-26 2019-09-10 Cytos Biotechnology Ag Scalable fermentation process
MX2007015039A (es) * 2005-06-06 2008-01-24 Novo Nordisk As Composiciones de il-21 estabilizadas.
US7858747B2 (en) * 2005-08-30 2010-12-28 Novo Nordisk A/S Expression of proteins in E.coli
EP2311995A1 (de) 2005-09-22 2011-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur Verwendung IL-21
CA2625208A1 (en) 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29
WO2007111714A2 (en) 2005-11-28 2007-10-04 Zymogenetics, Inc. Il-21 antagonists
EP1966232A1 (de) * 2005-12-23 2008-09-10 Novo Nordisk A/S Reinigung von proteinen mittels vorbereitender umkehrphasen-chromatographie
SG174013A1 (en) 2006-07-27 2011-09-29 Wyeth Corp High-cell density fed-batch fermentation process for producing recombinant protein
JP2010507382A (ja) 2006-10-26 2010-03-11 ノヴォ ノルディスク アクティーゼルスカブ Ｉｌ−２１変異体
US8211420B2 (en) 2006-12-21 2012-07-03 Novo Nordisk A/S Interleukin-21 variants with altered binding to the IL-21 receptor
CN101622269A (zh) * 2007-03-01 2010-01-06 诺沃-诺迪斯克有限公司 蛋白质在大肠杆菌中的表达
JP5358840B2 (ja) * 2007-11-24 2013-12-04 独立行政法人産業技術総合研究所 Ｇｆｐ（緑色蛍光蛋白質）の機能賦活・回復方法
US7883700B2 (en) 2007-12-07 2011-02-08 Zymogenetics, Inc. Anti-human IL-21 monoclonal antibodies
US9927440B2 (en) * 2009-11-25 2018-03-27 Duke University Protein engineering
WO2011149917A1 (en) * 2010-05-25 2011-12-01 Adlyfe, Inc. STABILIZED AMYLOID- β OLIGOMERS AND USES THEREOF
WO2013169693A1 (en) 2012-05-09 2013-11-14 Bristol-Myers Squibb Company Methods of treating cancer using an il-21 polypeptide and an anti-pd-1 antibody
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
WO2015178466A1 (ja) * 2014-05-21 2015-11-26 味の素株式会社 フィブロイン様タンパク質の製造法
RU2620073C2 (ru) * 2015-06-02 2017-05-22 Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России Оптимизированный ген, кодирующий рекомбинантный белок - аналог интерферона альфа-17 человека
RU2614264C2 (ru) * 2015-06-19 2017-03-24 Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России Оптимизированный ген, кодирующий рекомбинантный белок - аналог интерферона бета человека
RU2614124C9 (ru) * 2015-10-01 2020-04-22 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Оптимизированный ген, кодирующий рекомбинантный белок ипфiii
JP2017110001A (ja) * 2015-12-16 2017-06-22 株式会社 資生堂 タブレット型凍結乾燥化粧料
JP6404405B1 (ja) * 2017-06-14 2018-10-10 株式会社 資生堂 タブレット型凍結乾燥化粧料
US20210145705A1 (en) * 2017-06-19 2021-05-20 Shiseido Company, Ltd. Tablet-type freeze-dried cosmetic
WO2021074182A1 (en) * 2019-10-14 2021-04-22 Inbiose N.V. Production of bioproduct in a host cell
KR20230044394A (ko) * 2020-06-09 2023-04-04 아이코사백스, 인크. 바이러스 유사 입자를 제조하는 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4344697A (en) * 1996-10-04 1998-04-24 Amgen, Inc. Pharmaceutical compositions containing an mpl ligand
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US6307024B1 (en) 1999-03-09 2001-10-23 Zymogenetics, Inc. Cytokine zalpha11 Ligand
KR100743640B1 (ko) * 1999-03-09 2007-07-27 지모제넥틱스, 인코포레이티드 신규한 사이토킨 ｚａｌｐｈａ 11 리간드
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
CA2481304A1 (en) 2002-03-27 2003-10-09 Patrick Hwu Method for treating cancer in humans
WO2003087320A2 (en) 2002-04-09 2003-10-23 Beth Israel Deaconess Medical Center, Inc. Antagonists of il-21 and modulation of il-21-mediated t cell responses
JP2006525223A (ja) 2002-10-11 2006-11-09 ノボ・ノルデイスク・エー／エス Ｉｌ２１の使用によるアレルギー症状の治療
CN1513993A (zh) 2002-12-31 2004-07-21 北京博泰迪生物工程科技开发有限公司 中国人基因组cDNA文库白细胞介素21的编码基因序列及其蛋白质的氨基酸序列
WO2004112703A2 (en) 2003-06-19 2004-12-29 Centocor, Inc. Interleukin-21 analogs
CA2545024A1 (en) 2003-11-24 2005-06-02 Novo Nordisk A/S Fusion proteins and methods of cleavage of such proteins

Also Published As

Publication number Publication date
AU2003302250A1 (en) 2004-07-09
PL209009B1 (pl) 2011-07-29
KR20050090393A (ko) 2005-09-13
US20070048798A1 (en) 2007-03-01
US7767199B2 (en) 2010-08-03
EP1573006A4 (de) 2006-06-14
IL198074A0 (en) 2011-08-01
NO334561B1 (no) 2014-04-07
KR101098897B1 (ko) 2011-12-26
US20060134754A1 (en) 2006-06-22
EP1573006A2 (de) 2005-09-14
NO20053385L (no) 2005-07-12
DE60330044D1 (de) 2009-12-24
WO2004055168A2 (en) 2004-07-01
JP2006509525A (ja) 2006-03-23
IL168697A (en) 2011-10-31
ES2334127T3 (es) 2010-03-05
US20070048842A1 (en) 2007-03-01
AU2003302250B2 (en) 2009-08-27
BR0317243A (pt) 2005-11-01
EP1573006B1 (de) 2009-11-11
US7622561B2 (en) 2009-11-24
RU2005117338A (ru) 2006-03-20
MXPA05006117A (es) 2005-09-30
CA2507817A1 (en) 2004-07-01
CA2507817C (en) 2014-04-22
JP4664684B2 (ja) 2011-04-06
WO2004055168A3 (en) 2005-06-02
US7250274B2 (en) 2007-07-31
US20070048263A1 (en) 2007-03-01
RU2354703C2 (ru) 2009-05-10
PL377291A1 (pl) 2006-01-23
DK1573006T3 (da) 2010-03-22
US7745176B2 (en) 2010-06-29

Similar Documents

Publication Publication Date Title
ATE448298T1 (de) Il-21-produktion in prokaryontischen wirten
CY1112394T1 (el) Παραγωγη fgf18 σε προκαρυωτικους ξενιστες
Wu et al. CAMERS‐B: CRISPR/Cpf1 assisted multiple‐genes editing and regulation system for Bacillus subtilis
AU2002311989A1 (en) Methods and materials for the production of organic products in cells of $i(candida) species
MY207355A (en) Codon-optimized acid lpha-glucosidase expression cassettes and methods of using same
BR0115558A (pt) ácido nucleico isolado, construção de expressão recombinante, célula de levedura transformada com a construção de expressão recombinante, e, método para produzir ácido lático
DK1623023T3 (da) Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra
DK1945762T3 (da) Rationelt konstruerede meganucleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
Li et al. Arginine racemization by coupled catabolic and anabolic dehydrogenases
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
WO2019136618A1 (zh) 高产尿苷的基因工程菌及其构建方法与应用
CN103865944A (zh) 一种生产核黄素的大肠杆菌菌株及构建方法及用途
WO2005034876A3 (en) Use of cell lines to produce active therapeutic proteins
WO2004018630A3 (en) Recombinant double-stranded rna phages and uses thereof
AR043862A1 (es) Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina
Chen et al. Streptomyces aureorectus DSM 41692 and Streptomyces virens DSM 41465 are producers of the antibiotic nucleocidin and 4′-fluoroadenosine is identified as a co-product
Pilon et al. Ubiquitin fusion technology: bioprocessing of peptides
ATE382086T1 (de) Candida tropicalis cytochrom b5 gen und protein und verwendungen davon
AU2003260200A1 (en) Reversible, parallel and multitask cloning method and kit
AU5049100A (en) Phage-dependent super-production of biologically active protein and peptides
Zavilgelsky et al. Sequencing and comparative analysis of the lux operon of Photorhabdus luminescens strain Zm1: ERIC elements as putative recombination hot spots
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same
WO2007018744A3 (en) Cell-free biosynthesis of nucleic acid
DK1472347T3 (da) Forbedret proteinekspression i Bacillus Subtilis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1573006

Country of ref document: EP